Munich - 100,000 children took part in the bayernweitenz for early detection of type 1 diabetes. The Minister of Health in Bavaria announced today. According to the Helmholtz Zentrum München, the study will be continued and expanded to include an additional age group under the name “Fr1da-plus”: In addition to children aged two to five, nine and ten year olds can now take part.
A very early stage of type 1 diabetes has been diagnosed in numerous children. This is great success, ”said the patron of the study, Bavaria's Minister of Health Melanie Huml (CSU). She is pleased that the study is being expanded.
The Minister underlined: “It is important to have diabetes to be recognized as early as possible. Timely treatment makes it possible to prevent the later development of serious secondary diseases such as cardiovascular diseases or damage to the kidneys. With the help of 'Fr1da', numerous children have already been saved from the risk of life-threatening metabolic crisis. "
The" Fr1da "study has been running in Bavaria since January 2015." Type 1 diabetes affects more children every year and in most cases the families are surprised by the diagnosis, "said Matthias Tschöp, Managing Director of the Helmholtz Zentrum München.
As part of the study, parents in Bavaria can have their children between the ages of two and five - and now also at the age of nine or ten years - either as part of the children's preventive examinations (U7, U7a, U8, U9) or at any other pediatrician visit free of charge for an early stage of type 1 diabetes. To do this, few drops of blood are taken from the child's finger.
“Particularly serious are those cases that are hospitalized with dangerous metabolic imbalance (ketoacidosis) because the first symptoms have remained undetected. The early detection study enables parents to be sensitized and trained in good time and can thus contribute to avoiding this sometimes life-threatening condition, "emphasized Tschöp.
Children in whom the" Fr1da "study showed an early stage of type 1 diabetes is diagnosed, receive an individual care plan. The families concerned were personally informed, trained and advised.
158 families have so far also used the opportunity to take part in the prevention study. Doctors and scientists try to take insulin orally to slow down or even stop the progression of the disease.
"Our goal is to delay or prevent the progression of the autoimmune disease type 1 diabetes through treatment with oral insulin," explained Anette-Gabriele Ziegler, Director of the Institute for Diabetes Research at Helmholtz Zentrum München .
The Augsburg pediatrician Martin Lang, regional chairman of the in Bavaria and board member of confirms: “The demand shows us that the families have strong interest in bringing their children to an early stage of type 1 diabetes to be examined. That is why I and around half of all Bavarian paediatricians support the early detection of this chronic disease. We are happy that the possibility of early diagnosis with 'Fr1da-plus' is still secured. "